Abstract:Although immune signaling has emerged as a defining feature of the glioma microenvironment, how the underlying structure of the glioma-infiltrating T-cell population differs from that of the blood from which it originates has been difficult to measure directly in patients. High-throughput sequencing of T-cell receptor (TCR) repertoires (TCRseq) provides a population-wide statistical description of how T cells respond to disease. We have defined immunophenotypes of whole repertoires based on TCRseq of the α-and… Show more
“…Furthermore, a major advantage of S as a measure of T cell repertoire diversity is that it describes the physical distribution of a population such that it can be recreated and used for statistical modeling, which we apply in our approach for estimating the frequency of unseen clones. S emerges from the confirmation that the power law is the best model to describe the distribution for the bulk of TCR clones (22,25). The steepness of S reflects the difference in the number of rare clones on the left side of the distribution in an abundance plot compared with the number that are highly frequent on the right.…”
Section: Discussionmentioning
confidence: 99%
“…Scatter plots showing the number of individual clones shared between the 2 distinct alloreactive repertoires confirms their disparate nature for both CD4 + and CD8 + T cell repertoires ( Figure 4A). A standard quantitative measure of repertoire overlap is Jensen-Shannon divergence (JSD) (24,25), a tool that accounts for both clone number and frequency and is normalized on a scale of 0 to 1: a JSD of 1 indicates that all clones in 2 populations are distinct. A small group of high frequency shared clones was detected in the CD8 + repertoires of 2 of the 3 pairs (red in Figure 4A).…”
Section: Allostimulated Cd8mentioning
confidence: 99%
“…Interpopulation differences were determined by the JSD (47), which has previously been applied to TCR repertoire analysis (24,25). Rather than quantifying unevenness within a population, the JSD provides a measure of dissimilarity between the labeled frequencies of 2 populations.…”
“…Furthermore, a major advantage of S as a measure of T cell repertoire diversity is that it describes the physical distribution of a population such that it can be recreated and used for statistical modeling, which we apply in our approach for estimating the frequency of unseen clones. S emerges from the confirmation that the power law is the best model to describe the distribution for the bulk of TCR clones (22,25). The steepness of S reflects the difference in the number of rare clones on the left side of the distribution in an abundance plot compared with the number that are highly frequent on the right.…”
Section: Discussionmentioning
confidence: 99%
“…Scatter plots showing the number of individual clones shared between the 2 distinct alloreactive repertoires confirms their disparate nature for both CD4 + and CD8 + T cell repertoires ( Figure 4A). A standard quantitative measure of repertoire overlap is Jensen-Shannon divergence (JSD) (24,25), a tool that accounts for both clone number and frequency and is normalized on a scale of 0 to 1: a JSD of 1 indicates that all clones in 2 populations are distinct. A small group of high frequency shared clones was detected in the CD8 + repertoires of 2 of the 3 pairs (red in Figure 4A).…”
Section: Allostimulated Cd8mentioning
confidence: 99%
“…Interpopulation differences were determined by the JSD (47), which has previously been applied to TCR repertoire analysis (24,25). Rather than quantifying unevenness within a population, the JSD provides a measure of dissimilarity between the labeled frequencies of 2 populations.…”
“…To explore whether the global TCR diversity dynamics described above could also be detected at the level of individual VJ cassette combinations, we determined CDR3 richness and evenness for every VJ pair, as previously described (Sims et al, 2016). This approach, although more rigorous, is an in-silico descendant of traditional spectratyping, in which specific V and J cassette primers are used to amplify all CDR3s encoded by specific VJ cassette combinations and the products are analyzed by electrophoresis (Arstila et al, 1999).…”
Section: Star Methodsmentioning
confidence: 99%
“…This approach, although more rigorous, is an in-silico descendant of traditional spectratyping, in which specific V and J cassette primers are used to amplify all CDR3s encoded by specific VJ cassette combinations and the products are analyzed by electrophoresis (Arstila et al, 1999). The benefits of this in-silico approach are two-fold: 1) by examining diversity dynamics at the VJ cassette level, bias potentially introduced by preferential V and J cassette primer binding is diminished, and 2) a greater understanding of the extent to which antigen-binding properties (CDR3 amino acid sequences) versus VJ cassette usage biases influence global changes in TCR diversity is gained (Sims et al, 2016). Kernel density estimate plots of the number of CDR3s per VJ versus evenness of CDR3s per VJ were generated using the seaborn statistical data visualization platform for Python.…”
SUMMARY
The mechanisms by which immune checkpoint blockade modulates tumor evolution during therapy are unclear. We assessed genomic changes in tumors from 68 patients with advanced melanoma, who progressed on ipilimumab or were ipilimumab-naive, before and after nivolumab initiation (CA209-038 study). Tumors were analyzed by whole-exome, transcriptome, and/or T-cell receptor (TCR) sequencing. In responding patients, mutation and neoantigen load were reduced from baseline, and analysis of intratumoral heterogeneity during therapy demonstrated differential clonal evolution within tumors and putative selection against neoantigenic mutations on-therapy. Transcriptome analyses before and during nivolumab therapy revealed increases in distinct immune cell subsets, activation of specific transcriptional networks, and upregulation of immune checkpoint genes that were more pronounced in patients with response. Temporal changes in intratumoral TCR repertoire revealed expansion of T-cell clones in the setting of neoantigen loss. Comprehensive genomic profiling data in this study provide insight into nivolumab mechanism of action.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.